Before founding Murdin Biotechnology Consulting Inc. in 2010,  Andrew Murdin held the position of Senior Director, External R&D with sanofi pasteur, the world’s largest vaccine manufacturer. In this role he was based in Toronto, Canada, and was the senior member of sanofi pasteur’s North American External R&D team, responsible for identifying and evaluating novel scientific and technological developments by groups external to sanofi pasteur that were potential in-licensing or acquisition opportunities for sanofi pasteur.  He was a member of sanofi pasteur’s global Senior Leadership Team from 2007 to 2010. 

Dr. Murdin is a well-respected professional in the vaccine and biotechnology community. He has authored over 30 refereed papers and book chapters in the area of vaccine development, in addition to abstracts and conference presentations. He is an inventor on 40 granted US patents and 50 pending US patent applications, plus multiple corresponding international patents and patent applications.

Andrew Murdin will be attending the following upcoming events:

BioFinance 2012
Toronto, Canada - May 29-30, 2012

2012 Bio International Convention
Boston, USA - June 18-21, 2012

Prior to joining sanofi pasteur-Canada in 1990, Andrew Murdin was a post-doctoral researcher at the State University of New York, Stony Brook, NY, (1988-1990) and at the University of Surrey, UK (1985-1987). He holds a Ph.D. awarded by the University of Surrey in 1986 and a B.Sc awarded by the University of Bath, UK in 1980. 

MBCI provides scientific and technical opinions to senior managers in the biotechnology and pharmaceutical sectors in support of decision making around corporate strategy and corporate deal-making. MBCI also provides insight and advice regarding the business partnering practices of large pharma and biotech companies.